CSTL Sale Disclosure
Juvenal Tobin W · SEC Form 4 · Filed Oct 30, 2026
Sale
Calculated transaction value
$195.58K
Juvenal Tobin W Chief Commercial Officer
CSTL
Castle Biosciences
CSTL
Transaction date
Oct 28, 2026
Public filing date
Oct 30, 2026
Filing lag
Filed 2 days later
CSTL daily price context
Close on/before transaction
$36.68
Oct 28, 2026
First close after public filing
$34.94
Nov 2, 2026
Return after filing · so far
-6.93%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 5,341 shares @ $36.62
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001628280-26-068566
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$239.59K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Castle Biosciences Inc CSTL Current | Sale | Oct 28, 2026 | $195.58K |
| Castle Biosciences Inc CSTL | Sale | Oct 28, 2026 | $44.01K |